Skip to main navigation Skip to search Skip to main content

Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification

  • Maryam Kavousi*
  • , Maxime M. Bos
  • , Hanna J. Barnes
  • , Christian L.Lino Cardenas
  • , Doris Wong
  • , Haojie Lu
  • , Chani J. Hodonsky
  • , Lennart P.L. Landsmeer
  • , Adam W. Turner
  • , Minjung Kho
  • , Natalie R. Hasbani
  • , Paul S. de Vries
  • , Donald W. Bowden
  • , Sandesh Chopade
  • , Joris Deelen
  • , Ernest Diez Benavente
  • , Xiuqing Guo
  • , Edith Hofer
  • , Shih Jen Hwang
  • , Sharon M. Lutz
  • Leo Pekka Lyytikäinen, Lotte Slenders, Albert V. Smith, Maggie A. Stanislawski, Jessica van Setten, Quenna Wong, Lisa R. Yanek, Diane M. Becker, Marian Beekman, Matthew J. Budoff, Mary F. Feitosa, Chris Finan, Austin T. Hilliard, Sharon L.R. Kardia, Jason C. Kovacic, Brian G. Kral, Carl D. Langefeld, Lenore J. Launer, Shaista Malik, Firdaus A.A.Mohamed Hoesein, Michal Mokry, Reinhold Schmidt, Jennifer A. Smith, Kent D. Taylor, James G. Terry, Jeroen van der Grond, Joyce van Meurs, Rozemarijn Vliegenthart, Jianzhao Xu, Kendra A. Young, Nuno R. Zilhão, Robert Zweiker, Themistocles L. Assimes, Lewis C. Becker, Daniel Bos, J. Jeffrey Carr, L. Adrienne Cupples, Dominique P.v. de Kleijn, Menno de Winther, Hester M. den Ruijter, Myriam Fornage, Barry I. Freedman, Vilmundur Gudnason, Aroon D. Hingorani, John E. Hokanson, M. Arfan Ikram, Ivana Išgum, David R. Jacobs, Mika Kähönen, Leslie A. Lange, Terho Lehtimäki, Gerard Pasterkamp, Olli T. Raitakari, Helena Schmidt, P. Eline Slagboom, André G. Uitterlinden, Meike W. Vernooij, Joshua C. Bis, Nora Franceschini, Bruce M. Psaty, Wendy S. Post, Jerome I. Rotter, Johan L.M. Björkegren, Christopher J. O’Donnell, Lawrence F. Bielak, Patricia A. Peyser, Rajeev Malhotra, Sander W. van der Laan, Clint L. Miller*
*Corresponding author for this work
  • Harvard Medical School
  • University of Virginia
  • University of Virginia School of Medicine
  • University Medical Centre Utrecht
  • University of Michigan, Ann Arbor
  • Seoul National University
  • University of Texas Health Science Center at Houston
  • Wake Forest University
  • University College London
  • Leiden University Medical Centre
  • Max Planck Institute for Biology of Ageing
  • Utrecht University
  • The Lundquist Institute
  • Medical University of Graz
  • National Institutes of Health
  • Harvard Pilgrim Health Care
  • Tampere University
  • Icelandic Heart Association
  • University of Colorado Anschutz Medical Campus
  • University of Washington
  • Johns Hopkins School of Medicine
  • Washington University School of Medicine in St. Louis
  • VA Palo Alto Health Care System
  • Victor Chang Cardiac Research Institute
  • University of New South Wales
  • Icahn School of Medicine at Mount Sinai
  • University of California at Irvine
  • Vanderbilt University School of Medicine
  • University of Groningen
  • University Medical Centre Groningen
  • University of Colorado Denver
  • Stanford University School of Medicine
  • Erasmus University Rotterdam
  • Boston University School of Public Health
  • Amsterdam UMC
  • University of Iceland
  • School of Public Health
  • Tampere University Hospital and Tampere University
  • University of Turku
  • Turku University Hospital
  • University of Washington School of Medicine
  • University of North Carolina at Chapel Hill
  • Johns Hopkins Bloomberg School of Public Health
  • Karolinska Institutet
  • Hebrew SeniorLife
  • VA Medical Center

Research output: Contribution to journalArticleAcademicpeer-review

65 Citations (Scopus)

Abstract

Coronary artery calcification (CAC), a measure of subclinical atherosclerosis, predicts future symptomatic coronary artery disease (CAD). Identifying genetic risk factors for CAC may point to new therapeutic avenues for prevention. Currently, there are only four known risk loci for CAC identified from genome-wide association studies (GWAS) in the general population. Here we conducted the largest multi-ancestry GWAS meta-analysis of CAC to date, which comprised 26,909 individuals of European ancestry and 8,867 individuals of African ancestry. We identified 11 independent risk loci, of which eight were new for CAC and five had not been reported for CAD. These new CAC loci are related to bone mineralization, phosphate catabolism and hormone metabolic pathways. Several new loci harbor candidate causal genes supported by multiple lines of functional evidence and are regulators of smooth muscle cell-mediated calcification ex vivo and in vitro. Together, these findings help refine the genetic architecture of CAC and extend our understanding of the biological and potential druggable pathways underlying CAC.

Original languageEnglish
Pages (from-to)1651-1664
Number of pages14
JournalNature Genetics
Volume55
Issue number10
DOIs
Publication statusPublished - Oct 2023

Bibliographical note

Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer Nature America, Inc.

Fingerprint

Dive into the research topics of 'Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification'. Together they form a unique fingerprint.

Cite this